216 related articles for article (PubMed ID: 38112182)
1. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
2. Elafin as a Predictive Biomarker of Acute Skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
4. Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantation.
George L; Mahabal G; Mohanan E; Balasubramanian P; Peter D; Pulimood S; Lakshmi K; Jeyaseelan L; Abraham A; Srivastava A; Mathews V; George B
Clin Exp Dermatol; 2021 Dec; 46(8):1482-1487. PubMed ID: 34081805
[TBL] [Abstract][Full Text] [Related]
5. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
[TBL] [Abstract][Full Text] [Related]
8. Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease.
Wang B; Yin Y; Li Y; Liang Z; Liu W; Sun Y; Dong Y; Ren H
Transplant Proc; 2023 Sep; 55(7):1706-1714. PubMed ID: 37385841
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
[TBL] [Abstract][Full Text] [Related]
10. Elafin is a biomarker of graft-versus-host disease of the skin.
Paczesny S; Braun TM; Levine JE; Hogan J; Crawford J; Coffing B; Olsen S; Choi SW; Wang H; Faca V; Pitteri S; Zhang Q; Chin A; Kitko C; Mineishi S; Yanik G; Peres E; Hanauer D; Wang Y; Reddy P; Hanash S; Ferrara JL
Sci Transl Med; 2010 Jan; 2(13):13ra2. PubMed ID: 20371463
[TBL] [Abstract][Full Text] [Related]
11. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
12. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
[TBL] [Abstract][Full Text] [Related]
13. Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study.
Mahabal GD; George L; Peter D; Bindra M; Thomas M; Srivastava A; Mathews V; George B; Pulimood SA
Clin Exp Dermatol; 2019 Mar; 44(2):161-168. PubMed ID: 29882232
[TBL] [Abstract][Full Text] [Related]
14. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: Systematic review and meta-analysis of randomised and non-randomised studies.
Zhang MY; Zhao P; Zhang Y; Wang JS
PLoS One; 2022; 17(7):e0271979. PubMed ID: 35905125
[TBL] [Abstract][Full Text] [Related]
16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
17. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
20. Decline of serum albumin precedes severe acute GVHD after haploidentical HSCT.
Takahashi N; Mochizuki K; Sano H; Kobayashi S; Ohara Y; Ikeda K; Ohto H; Kikuta A
Pediatr Int; 2021 Sep; 63(9):1048-1054. PubMed ID: 33253440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
